To prevent respiratory virus (RV) infection after hematopoietic SCT (HSCT), patient and household members are advised to have annual influenza vaccinations and avoid symptomatic contacts. The object of this study was to measure and increase patient/household awareness of RV infection and preventive measures. We used a selfadministered questionnaire before/after a 5-min educational module (2006)(2007) and interviews with HSCT patients (2005with HSCT patients ( -2007. The subjects were patients and their households attending pre-HSCT education in an Australian HSCT Unit. Outcome measures were awareness of RV infection post-HSCT and effective prevention strategies; household influenza vaccination on admission for HSCT. In all, 139 out of 205 (68%) participants completed both questionnaires. Baseline knowledge of RV infection risk was high; knowledge of prevention was low. Intervention increased awareness that influenza post-HSCT could be fatal or require intensive care (68-87%, P ¼ 0.003), knowledge of effective prevention strategies (41-78%, Po0.0001) including vaccination (11-58%, Po0.0001), and belief among family/friends (but not patients) that household vaccination reduces influenza risk post-HSCT (57-97%, Po0.0001 and 76-81%, P ¼ 0.2, respectively). Household vaccination at HSCT admission was 71% for attenders and 30% for non-participants (RR 2.38, 95% confidence interval (CI) 1.49-3.80, Po0.0001). We concluded that patient and family pre-HSCT education increases awareness of RV prevention strategies and household influenza vaccination.
Introduction
Respiratory virus (RV) infections after hematopoietic SCT (HSCT) are common. 1, 2 Although the majority are upper respiratory tract infections, [1] [2] [3] [4] [5] pneumonia historically occurs in 16-45% of all RV episodes, [1] [2] [3] and up to 80% of influenza. 6 Early treatment with oseltamavir has been shown to reduce the incidence of pneumonia in cases of influenza to o30% with an associated mortality o10%. 7, 8 The widespread emergence of antiviral resistance 9 raises concern that these improvements may, however, not be sustained. There have been 7 reported cases of oseltamavir resistant influenza in HSCT recipients and other immunosuppressed patients. Six patients developed pneumonia, and of these, 4 resulted in death from respiratory failure. [10] [11] [12] Preventing RV infection in HSCT recipients remains essential. The main preventive measures are influenza vaccination and avoiding contact with infected individuals. Parenteral inactivated influenza vaccine reduces confirmed influenza cases by 70% in healthy adults, 13 but produces a poor Ab response within 6 months post-HSCT, 14 particularly in allograft recipients. 15 Immunizing family members and caregivers (ring vaccination) can reduce infection risk, 16 and is particularly important immediately following HSCT. 17 Influenza vaccination guidelines in Australia, 18 Europe 19 and the United States of America 20 recommend immunization for all household contacts and healthcare workers involved with HSCT recipients, with annual immunization recommended 6 months post-HSCT. [17] [18] [19] [20] Separating HSCT recipients from symptomatic healthcare workers and visitors is also recommended. 20 There is scant evidence concerning awareness and uptake of preventive measures among HSCT patients or their families-even though these measures require their cooperation. According to the health belief model, 21 the likelihood of uptake depends on perceptions of the patient's susceptibility to RV infections, the severity of infection and its consequences; costs and benefits of adopting the measure and barriers to doing so; and external cues such as reminders and persuasive communications. 22 We report findings of a study that aims:- (1) to ascertain what HSCT patients and their family and friends know about the risk of RV infections post-HSCT, and measures to prevent them, and (2) to evaluate a brief educational intervention designed to increase awareness of preventive measures and increase uptake of household influenza vaccination.
Patients and methods

Setting and participants
Patients, their relatives and friends were eligible for the study if they attended a half-day educational forum run every second month by HSCT unit staff at Westmead Hospital, Sydney, Australia. Patients are invited to attend within 2 months of the scheduled admission for HSCT.
Intervention
Using the health belief model, 21 a 5-minute education session was developed to inform patients/caretakers about the risks of RV infection, preventive measures and their efficacy. This was incorporated into the existing education forum (April 2005) using a standardized format and was evaluated over nine consecutive sessions with the same presenter (April 2006-August 2007). Participants received a letter, addressed to their general practitioner, requesting influenza vaccination.
Evaluation
Self-administered questionnaires were distributed to all attenders before and after the session. Patients admitted for HSCT between July 2005 and September 2007 were asked about attendance at the forum and household influenza vaccination. Attendance was confirmed using records kept by the forum organizer. Vaccination uptake used selfreport from patients and other family members present on admission.
Responses were analyzed using SPSS 15.0. The Pearson w test was used to analyze differences in proportions, Wilcoxon's signed rank test and Mann-Whitney test for non-parametric continuous variables. Statistical significance was set at P ¼ 0.05 and two-tailed P-values were calculated. Approval was granted by the South Western Sydney Area Health Service Ethics Committee.
Results
Both baseline and follow-up questionnaires were completed by 139 out of 205 (68%) forum participants: 43 (31%) patients, 88 (63%) family members and 8 (6%) friends. Half of the family/friends (47 out of 96, 49%) lived with the patient preparing for HSCT. Most patients were male (25 out of 43, 58%, median age 49.5 years, range 21-71 years). Most family and friends were female (62 out of 96, 65%, median age 46.5 years, range 13-83 years). Information on vaccination was gathered from 122 out of 134 (91%) patients admitted for HSCT, with 70 (57%) patients/ families attending an education forum.
Baseline measures indicated sound understanding of the cause of respiratory infections and the proportion attributable to RVs after HSCT, and this improved at follow up (Table 1) . Initially, 32% of respondents (45 out of 139) did not acknowledge that influenza post-HSCT could be fatal or require intensive care, and this figure more than halved after the education session (18 out of 139, 13%, P ¼ 0.003). Although the proportion of patients and family/friends that underestimated the risk of death or need for intensive care management was similar at baseline (42% of patients and 28% of family/friends, P ¼ 0.1) patients persistently underestimated this risk following education (21% of patients and 9% of family/ friends, P ¼ 0.01).
Awareness of effective prevention strategies was low at baseline ( Table 2 ). Only 41% of respondents listed at least one effective strategy. This increased to 78% at follow up (Po0.0001). Avoiding symptomatic contacts was the most frequently listed preventive measure at baseline. Although this did not increase post-intervention, awareness of vaccination did increase from 11 to 58% (Po0.0001). Belief in the benefit of family vaccination increased among family/friends (57-97%, Po0.0001) but not among patients (76-81%, P ¼ 0.2), and was significantly lower than in family/friends (P ¼ 0.008).
Before the forum, 93% of family/friends indicated willingness to be vaccinated against influenza to reduce the patient's risk of infection. When stratified for belief in the efficacy of vaccination, 98% of 'believers' indicated willingness to be vaccinated, compared with 80% of 'nonbelievers' and 88% who were unsure (P ¼ 0.05). After the forum, all responders indicated willingness to be vaccinated (P ¼ 0.03).
At the education forum, 18 out of 43 (42%) patients preparing for HSCT had ever received influenza vaccination. The corresponding figure for family/friends was 43 out of 96 (45%), 30 out of 96 (31%) within the preceding year. Among family/friends aged X65 years, 50% (7 out of 14) had received vaccination within 12 months compared with 28% (23 out of 82) aged o65 years (P ¼ 1.0). Half of the patients were aware that at least one family member had received influenza vaccination within 12 months (21 out of 43, 49%).
Households of patients admitted for HSCT had a median (twenty-fifth quartile, seventy-fifth quartile) of 2.0 (1.0, 3.0) additional members, 1.0 (1.0, 2.0) adult and 0.0 (0.0, 1.0) children, and were similar between the groups. On admission for HSCT, household influenza vaccination in the preceding 12 months was greater in attenders than non-attenders (Table 3) , with vaccination of at least one member in 44 out of 62 (71%) and 14 out of 47 (30%) households (RR 2.38, 95% CI 1.49-3.80, Po0.0001), and of all members in 30 out of 62 (48%) and 7 out of 47 (15%) households (RR 3.57, 95% CI 1.76-7.25, Po0.0001), respectively. Vaccination of all adults was more likely than all children in attenders (61 and 39%, P ¼ 0.04) but not non-attenders (23 and 16%, P ¼ 0.5).
Information on reasons household members had or had not received influenza vaccination was gathered from a subset of 33 patients admitted for HSCT in the last 6 months of the study (27% of total population). In half of the households represented in this sub-sample (16 out of 33, 49%), at least one household member had been vaccinated. This was more likely to have occurred in households of patients who had attended the forum (10 out of 18, 56%) compared with households of non-attenders (6/15, 40%). Of the 16 households where members had received vaccination, 13 (81%) reported this had been prompted by education about the need for it. This figure includes 10 patients who attended the forum, and 3 non-attenders who had followed a recommendation by their HSCT physician. In the remaining three households, members were routinely vaccinated each year. In households that had not been immunized, the main reason reported was the lack of knowledge of influenza vaccination and its indication in this setting (3 out of 8 that had attended the forum, 8 out of 9 that had not attended, P ¼ 0.09). Other reasons given were the cost (3 out of 17), difficulty accessing a medical practitioner (1 out of 17), recent illness (1 out of 17) and difficulties vaccinating children when child-rearing is shared between two homes (1 out of 17).
Influenza vaccination during the previous 12 months was reported in only 22 out of 122 (18%) patients on admission for HSCT. Patients had been diagnosed with the condition for which they required HSCT a median of 11 months (5.0, 23.0) before HSCT (acute myeloid or lymphoblastic leukemia (64 out of 122, 52%); other hematological malignancies (39 out of 122, 32%); non-malignant hematological diseases (17 out of 122, 14%); and nonhematological malignancies (2 out of 122, 2%)).
Discussion
Our findings suggest that patients preparing for HSCT, and their families and friends, understand that RVs pose a risk to patients after transplantation, but they underestimate its severity and lack knowledge on effective prevention methods. A brief information session nested in a broader educational forum increased knowledge and acceptability of prevention methods, particularly family influenza vaccination, with an associated increase in household vaccination evident at the time of HSCT admission. Improvements in knowledge and acceptability were greater in family/friends than in patients.
These findings are subject to biases. Low attendance at the forum (57%) is likely due to several factors including travel costs (50% patients live 4100 km from the hospital), language barriers and urgency of admission. Reassuringly, those who completed only one questionnaire were comparable to those who completed both with respect to gender, age and responses. Those who attend education forums are likely to be more motivated than non-attenders, however, and are probably more likely to respond to educational messages. It is important for health-care professionals working in the HSCT setting to consider alternative methods to educate non-attenders. In a sub-sample of study participants, 3 out of 16 (19%) households of patients who did not attend the education forum were immunized after a recommendation from their HSCT physician. Brief health promotion advice from physicians has been shown to be effective in other settings, most notably in smoking cessation. 23 Social desirability bias (the tendency to give answers the researchers want rather than those that best reflect one's own views) would explain why, at baseline, 93% of family/ friends indicated willingness to be vaccinated for the patient's benefit, regardless of their belief in its efficacy. Information on household vaccine uptake was gathered at the time of HSCT admission, and reported by patients and other family members present during the interview. Although validation studies have shown that self-reporting of influenza vaccination is reliable in elderly patients, 24, 25 reporting by other household members has not been assessed, and may lack reliability. We did not assess avoidance of symptomatic contacts because of the practical difficulty of doing so. Nor did we evaluate the impact of forwarding a letter to the patient's and household's physician requesting influenza vaccination.
Influenza vaccination rates in both patients and family/ friends were low in this study. Vaccination within 12 months was reported by only 50% of family/friends aged X65 years (for whom vaccination is recommended in national guidelines 17 ) at the education forum. This is lower than rates of 468% reported in comparable groups in Australia, 26 the United Kingdom 27 and United States of America. 28 Vaccination uptake of 18% in patients preparing for HSCT (for whom annual influenza vaccination is recommended) is particularly low, despite the majority of patients having a diagnosis of malignancy an average of 11.0 months before HSCT.
In summary, a brief education session in the lead up to HSCT increased knowledge of RV infections post-HSCT and measures to prevent this. After the session we observed important discrepancies between patient and household regarding knowledge and beliefs about the benefit of household vaccination, and these highlight the importance of educating families.
On the basis of these data, additional research and effort need to be aimed at increasing the uptake of influenza vaccination in patients and families, and increasing uptake of other preventive strategies. Further study will evaluate the contribution the physician letter has made to household vaccination and if annual vaccination of patient and household is sustained. Future research will also evaluate the effect patient and family education and vaccination has on reducing RV infections post-HSCT.
